Insulin lispro
赖脯胰岛素
Report date: 2026/03/31 20:00:21
Base Information
Drug NameInsulin lispro
Drug Alias Name +[16]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[15]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1996/04/30
Country/Territory +[33]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesLilly France SasStanford UniversityEli Lilly And Company +[12]
Inactive CompaniesGan And Lee Pharmaceuticals, UsaBecton Dickinson And Company LtdMedical University Of Graz +[10]
Active Indications +[11]
Inactive Indications +[4]